Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States.
| Revenue (Most Recent Fiscal Year) | $6.55B |
| Net Income (Most Recent Fiscal Year) | $-530.20M |
| PE Ratio (Current Year Earnings Estimate) | 17.52 |
| PE Ratio (Trailing 12 Months) | 17.32 |
| PEG Ratio (Long Term Growth Estimate) | 10.72 |
| Price to Sales Ratio (Trailing 12 Months) | 1.46 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.71 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 9.38 |
| Pre-Tax Margin (Trailing 12 Months) | -7.19% |
| Net Margin (Trailing 12 Months) | -8.81% |
| Return on Equity (Trailing 12 Months) | 9.92% |
| Return on Assets (Trailing 12 Months) | 4.75% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.78 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.18 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.65 |
| Inventory Turnover (Trailing 12 Months) | 5.50 |
| Book Value per Share (Most Recent Fiscal Quarter) | $8.32 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.21 |
| Earnings per Share (Most Recent Fiscal Year) | $0.90 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.84 |
| Exchange | NYSE |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Common Shares Outstanding | 676.36M |
| Free Float | 674.47M |
| Market Capitalization | $9.60B |
| Average Volume (Last 20 Days) | 6.21M |
| Beta (Past 60 Months) | 0.89 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.28% |
| Percentage Held By Institutions (Latest 13F Reports) | 95.08% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |